SEC Form 5 · accession 0001570523-18-000011
Immune Therapeutics, Inc. · IMUN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Period of report
Dec 31, 2017
Accepted (ET)
Mar 30, 2018 · 2:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001559356
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock | Jan 27, 2016 | P | 200 | $0.1923 | A | 20,800,359 | D | |
| Common stock | Jan 28, 2016 | P | 1,000 | $0.185 | A | 20,800,359 | D | |
| Common stock | Jan 29, 2016 | P | 7,000 | $0.18 | A | 20,800,359 | D | |
| Common stock | Feb 2, 2016 | P | 100 | $0.193 | A | 20,800,359 | D | |
| Common stock | Feb 3, 2016 | P | 1,250 | $0.1874 | A | 20,800,359 | D | |
| Common stock | Feb 3, 2016 | P | 750 | $0.189 | A | 20,800,359 | D | |
| Common stock | Feb 8, 2016 | P | 1,000 | $0.1888 | A | 20,800,359 | D | |
| Common stock | Feb 8, 2016 | P | 1,000 | $0.19 | A | 20,800,359 | D | |
| Common stock | Feb 9, 2016 | P | 1,000 | $0.188 | A | 20,800,359 | D | |
| Common stock | Feb 11, 2016 | P | 1,000 | $0.1899 | A | 20,800,359 | D | |
| Common stock | Feb 11, 2016 | P | 500 | $0.1899 | A | 20,800,359 | D | |
| Common stock | Feb 16, 2016 | P | 1,250 | $0.1767 | A | 20,800,359 | D | |
| Common stock | Feb 16, 2016 | P | 750 | $0.1795 | A | 20,800,359 | D | |
| Common stock | Feb 17, 2016 | P | 1,000 | $0.1774 | A | 20,800,359 | D | |
| Common stock | Feb 17, 2016 | P | 1,000 | $0.1775 | A | 20,800,359 | D | |
| Common stock | Feb 17, 2016 | P | 1,000 | $0.1762 | A | 20,800,359 | D | |
| Common stock | Feb 18, 2016 | P | 5,000 | $0.173 | A | 20,800,359 | D | |
| Common stock | Feb 18, 2016 | P | 1,000 | $0.1745 | A | 20,800,359 | D | |
| Common stock | Feb 18, 2016 | P | 1,000 | $0.1777 | A | 20,800,359 | D | |
| Common stock | Feb 29, 2016 | P | 1,000 | $0.1474 | A | 20,800,359 | D | |
| Common stock | Feb 29, 2016 | P | 500 | $0.1492 | A | 20,800,359 | D | |
| Common stock | Feb 29, 2016 | P | 10,000 | $0.1675 | A | 20,800,359 | D | |
| Common stock | Feb 29, 2016 | P | 10,000 | $0.17 | A | 20,800,359 | D | |
| Common stock | Feb 29, 2016 | P | 1,250 | $0.168 | A | 20,800,359 | D | |
| Common stock | Feb 29, 2016 | P | 5,000 | $0.1709 | A | 20,800,359 | D | |
| Common stock | Feb 29, 2016 | P | 5,000 | $0.171 | A | 20,800,359 | D | |
| Common stock | Feb 29, 2016 | P | 3,750 | $0.171 | A | 20,800,359 | D | |
| Common stock | Mar 1, 2016 | P | 5,500 | $0.1659 | A | 20,800,359 | D | |
| Common stock | Mar 1, 2016 | P | 10,000 | $0.1659 | A | 20,800,359 | D | |
| Common stock | Mar 1, 2016 | P | 1,250 | $0.1648 | A | 20,800,359 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
This is part 7 of 16 submissions.